top of page

Most women with a common type of early-stage breast cancer can skip chemo

The majority of women with the most common type of early-stage breast cancer can safely skip chemotherapy after surgery, according to a highly anticipated new report. The results, released Sunday, are sure to accelerate the decline in chemotherapy for the disease.

The findings came from the largest breast cancer treatment trial ever conducted and showed that most patients who have an intermediate risk of a cancer recurrence — a group that numbers 65,000 women a year in the United States — can avoid chemotherapy and its often debilitating side effects.

“We have been waiting for these results for years,” said Allison Kurian, an oncologist at Stanford University who was not involved in the trial. “They are going to change treatment and remove uncertainty for women making decisions.”

To read the full article, click HERE

(Eva Deitch/For The Washington Post)

Featured Posts
Recent Posts
Search By Tags
bottom of page